by Susan Johnson | Jul 30, 2013 | Clinical Trial, JBR Clinical Research
Hepatitis C is a contagious infection that causes inflammation of the liver tissue. Over time Hepatitis C can cause severe damage to the liver. There are often few early signs of Hepatitis C infection: often patients are unaware of their infection until years later...
by Susan Johnson | Jul 30, 2013 | Clinical Trial, JBR Clinical Research
There are existing treatments for Hepatitis C. Because the infection may be mild, treatment is not always necessary. Individuals with slight liver abnormalities may require only follow-up blood tests to monitor the liver function. In fact, approximately 10% to 25% of...
by Susan Johnson | Jul 30, 2013 | Clinical Trial, JBR Clinical Research
What is Hepatitis C? Hepatitis C is an infection that targets the liver. The term “hepatitis” means inflammation of the liver; there are several strains of hepatitis that infect the liver. Generally considered one of the most serious of the hepatitis virus, Hepatitis...
